Title
Category
Credits
Event date
Cost
New Tools for Breast Cancer Risk Assessment
  • Breast Cancer
  • 0.50 AAPA Category 1 CME credit
  • 0.50 ACPE contact hours
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 ANCC contact hours
  • 0.50 Participation
$0.00
It is important for clinicians to learn about these risk assessment models, understand their limitations and benefits, and determine the best breast cancer risk reduction strategy that can be used for an individual.
Updates in Metastatic Colorectal Cancer
  • Colorectal Cancer
  • 0.75 AAPA Category 1 CME credit
  • 0.75 ACPE contact hours
  • 0.75 AMA PRA Category 1 Credit™
  • 0.75 ANCC contact hours
  • 0.75 Participation
$0.00
As options for treatment of metastatic colorectal cancer evolve, clinicians can benefit from education about available options and criteria for selecting the appropriate option to offer their patients. An overview of these newer treatment options, and the data supporting these, should help clinicians better serve their patients with metastatic colorectal cancer.
Recorded Presentations from the NCCN 2025 Annual Conference
$0.00
The NCCN 2025 Annual Conference addressed timely and important educational needs of cancer care providers to improve and facilitate quality, effective, equitable and accessible cancer care so patients can live better lives.The conference focuses on the practical management of patients living with or at risk for cancer, provides updates of NCCN Guidelines, and includes educational sessions on new treatments, therapies, and trends, and their application in patient care. The conference also provides a venue for education around best practices for cancer care delivery.
Treatment Updates for Small Cell Lung Cancer
  • Lung Cancers
  • 0.50 AAPA Category 1 CME credit
  • 0.50 ACPE contact hours
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 ANCC contact hours
  • 0.50 Participation
$0.00
After decades of no change in treatment, practice changing therapies have now been added to the NCCN Guidelines for Small Cell Lung Cancer. This activity will help clinicians keep up to date with practice-changing strategies for SCLC.
Plenary Session: Artificial Intelligence in Cancer Care: Opportunities, Challenges, and Governance
  • Best Practices
  • 1.25 AAPA Category 1 CME credit
  • 1.25 ACPE contact hours
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 ANCC contact hours
  • 1.25 Participation
$0.00
Education in this topic is important as AI is increasingly incorporated into care settings. Practitioners may not be aware of the way AI is currently being used or of its potential future application. Additionally, healthcare professionals need to be informed of the policy environment for the safe and effective use of AI in healthcare settings.
Artificial Intelligence: Evaluation and Success Criteria for AI Tools
  • Best Practices
  • 0.75 AAPA Category 1 CME credit
  • 0.75 ACPE contact hours
  • 0.75 AMA PRA Category 1 Credit™
  • 0.75 ANCC contact hours
  • 0.75 Participation
$0.00
With the promise of artificial intelligence (AI) and its potential to positively impact healthcare, comes the challenge of how to assess the feasibility and value associated with implementation of AI tools.
Improving Clinical Trial Accrual: Doing More with Less
  • Best Practices
  • 0.50 AAPA Category 1 CME credit
  • 0.50 ACPE contact hours
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 ANCC contact hours
  • 0.50 Participation
$0.00
Traditional recruitment to clinical trials was accomplished by outreach from the treating physician or staff associated with the clinical trial. It is important for clinicians to be aware of the logistics and the value that a clinical trial matching tool can bring to presenting a person with cancer the appropriate clinical trial.
Expanding the Reach of Clinical Trials
  • Best Practices
  • 0.75 AAPA Category 1 CME credit
  • 0.75 ACPE contact hours
  • 0.75 AMA PRA Category 1 Credit™
  • 0.75 ANCC contact hours
  • 0.75 Participation
$0.00
Although we have made some progress in ways of increasing clinical trial access to underserved communities, inequities persist. Education in this area is important because increasing access to clinical trials will have a positive impact on patient outcomes and help address current disparities in cancer treatment.
Innovative Strategies to Improve Patient Access
  • Best Practices
  • 1.00 AAPA Category 1 CME credit
  • 1.00 ACPE contact hours
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC contact hours
  • 1.00 Participation
$0.00
Technology advancements in recent years have created many opportunities for improving patient access, including opportunities for self-scheduling. As practices are investing significant resources in this space it is important to understand the challenges, limitations, and impacts of these innovative approaches to solving patient access issues.
Reducing Intersectional Stigmas to Improve Outcomes in People Impacted by Cancer
  • Best Practices
  • 0.75 AAPA Category 1 CME credit
  • 0.75 ACPE contact hours
  • 0.75 AMA PRA Category 1 Credit™
  • 0.75 ANCC contact hours
  • 0.75 Participation
$0.00
Intersectional stigmas in cancer care can exacerbate disparities by compounding the challenges faced by individuals who belong to multiple marginalized groups, leading to inequities in access, treatment, and outcomes. There is often a lack of consistent implementation of screening and support services that address the unique needs of marginalized patients, resulting in disparities in early detection, treatment, and follow-up care.

Pages